Provider-directed metabolic weight loss programs. Our physician designs personalized protocols based on your clinical evaluation, lab results, and body composition data.
Our weight loss protocols utilize evidence-based therapies, including GLP-1 receptor agonists, to support metabolic health and weight reduction. These therapies work alongside customized lifestyle and nutritional guidance to target the biological mechanisms of weight management.
Treatments may include medications prescribed based on clinical evaluation, evaluated and prescribed by our licensed medical provider following a full clinical evaluation, lab review, and baseline body composition analysis.
A GLP-1 receptor agonist used in provider-prescribed weight loss programs. Your physician will evaluate whether this therapy is appropriate based on your individual health history and goals.
Learn MoreA dual GIP/GLP-1 receptor agonist used in provider-prescribed metabolic programs. Candidacy is determined following a full clinical evaluation and lab review by our physician.
Learn MorePublished research on the FDA-approved branded medication Wegovy (semaglutide 2.4mg) demonstrated significant weight loss outcomes. These results reflect the studied branded formulation and may not apply to compounded versions.
Read Published StudyPublished research on the FDA-approved branded medication Zepbound (tirzepatide) demonstrated significant weight loss in trial participants. These results reflect the studied branded formulation.
Read Published StudyPublished long-term studies on GLP-1 receptor agonists continue to demonstrate their capability in treating chronic metabolic conditions when combined with lifestyle interventions and physician guidance.
In-clinic in Naperville or via telehealth.
Or call us at 630-857-9333
